Skip to Main Content
Kathleen Ludwig, M.D.

Kathleen Ludwig, M.D.

Titles and Appointments

Associate Professor

Schools
Medical School
Departments
Pediatrics

You have reached the Academic Profile.

For more information on the doctor and patient care, please visit the clinical profile.

  • Biography

    Dr. Ludwig is a board-certified pediatric oncologist, with a special interest in the care of patients with leukemia, lymphoma, relapsed leukemia, or lymphadenopathy, as well as managing general pediatric oncology disorders. She also devotes a dedicated part of her practice to treating patients with vascular anomalies. She is an active member of the Children’s Oncology Group and serves as the institutional principal investigator for numerous early phase I trials aiming to improve survival in patients with refractory/relapsed leukemia.

    Dr. Ludwig feels that families play a vital role in the care of a child with cancer and works with them to provide the best, most informed care possible. 

  • Education
    Medical School
    Loyola University Chicago Stritch School of Medicine (2009)
    Residency
    UT Southwestern/Children's Medical Center (2012), Pediatrics
    Fellowship
    UT Southwestern/Children's Medical Center (2015), Pediatric Hematology/oncology
  • Research Interest
    • Leukemia
    • Vascular Anomalies
  • Publications
    A Case Series of Peritoneal Mesothelioma in Pediatric Patients
    Merritt A, Ludwig K, Polanco PM, Sengupta A, Sadanand A Journal of Pediatric Hematology/Oncology 2026 Mar 48 e105-e108
    An analysis of diagnostic metabolomic profiles associated with hepatotoxicity during childhood ALL induction therapy
    Mason EJ, Crain AM, Scheurer ME, Lupo PJ, Rabin KR, Taylor OA, Roberts M, Woodhouse JP, Chavana A, Ludwig K, Klesse L, Heym K, Griffin T, Erana R, Bernini JC, Gramatges MM, Yi JS, Pruitt SL, Bernhardt MB, Zhu H, Mittelman SD, Huynh V, Orgel E, Schraw JM, Brown AL Blood Advances 2025 Nov 9 5802-5810
    Prediction of methotrexate neurotoxicity using clinical, sociodemographic, and area-based information in children with acute lymphoblastic leukemia
    Harris RD, Taylor OA, Gramatges MM, Hughes AE, Zobeck M, Pruitt S, Bernhardt MB, Chavana A, Huynh V, Ludwig K, Klesse L, Heym K, Griffin T, Erana R, Bernini JC, Choi A, Ohno Y, Richard MA, Morrison AC, Chen H, Yu B, Lupo PJ, Rabin KR, Scheurer ME, Brown AL Oncologist 2025 Jun 30
    Larotrectinib for Newly Diagnosed Infantile Fibrosarcoma and Other Pediatric NTRK Fusion-Positive Solid Tumors (Children's Oncology Group ADVL1823)
    Laetsch TW, Voss S, Ludwig K, Hall D, Barkauskas DA, Dubois SG, Ronan J, Rudzinski ER, Memken A, Robinson K, Sorger J, Reid JM, Bhatla T, Crompton BD, Church AJ, Fox E, Weigel BJ Journal of Clinical Oncology 2025 Apr 43 1188-1197
    Evaluation of methotrexate Pharmacogenomic variation to predict acute neurotoxicity in children with acute lymphoblastic leukemia
    Harris RD, Taylor OA, Gramatges MM, Hughes AE, Zobeck M, Pruitt S, Bernhardt MB, Chavana A, Huynh V, Ludwig K, Klesse L, Heym K, Griffin T, Erana R, Bernini JC, Choi A, Ohno Y, Richard MA, Morrison AC, Chen H, Yu B, Lupo PJ, Rabin K, Scheurer ME, Brown AL Pharmacotherapy 2025 Jan 45 4-11
    Phase II Study of Samotolisib in Children and Young Adults With Tumors Harboring Phosphoinositide 3-Kinase/Mammalian Target of Rapamycin Pathway Alterations: Pediatric MATCH APEC1621D
    Laetsch TW, Ludwig K, Williams PM, Roy-Chowdhuri S, Patton DR, Coffey B, Reid JM, Piao J, Saguilig L, Alonzo TA, Berg SL, Mhlanga J, Fox E, Weigel BJ, Hawkins DS, Mooney MM, Takebe N, Tricoli JV, Janeway KA, Seibel NL, Parsons DW JCO Precision Oncology 2024 Sep 8
    Genomic heterogeneity within B/T mixed phenotype acute leukemia in a context of an immunophenotype
    Zheng R, Fuda F, Gagan J, Weinberg OK, Koduru P, Cantu M, Ludwig K, Truscott JM, Collins R, Chung S, Madanat YF, Chen W Leukemia Research Reports 2024 Jan 21
    Early therapy with sirolimus reduces size of a large solid renal mass but not seizure activity in an infant with tuberous sclerosis
    Hani SB, Artunduaga M, Ludwig K, Bissler JJ, Wolf MT Journal of Nephrology 2024 Jan 37 203-205
    Recent progress in the treatment of cancer in children
    Butler E, Ludwig K, Pacenta HL, Klesse LJ, Watt TC, Laetsch TW CA Cancer Journal for Clinicians 2021 Jul 71 315-332
    Giant congenital melanocytic nevus treated with trametinib
    Mir A, Agim NG, Kane AA, Josephs SC, Park JY, Ludwig K Pediatrics 2019 Mar 143
  • Honors & Awards
    • Best Pediatric Subspecialist
      D-Magazine (2021-2023)
    • Best Poster award
      UT Southwestern Pediatric Fellow's Research Symposium (2015)
    • Best Basic Science Award
      Annual Surgical Research Forum, UT Southwestern (2014)
    • Above-and-Beyond Recognition for Excellence
      UT Southwestern Pediatric Residency Program (2010)
  • Professional Associations/Affiliations
    • American Society of Clinical Oncology (2013)
    • American Society of Hematology (2013)
    • American Society of Pediatric Hematology/Oncology (2013)
    • Children’s Medical Center Oncology Group (2013)